Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer-Reference-Cited by-同舟云学术

Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer

Published:2009-06-15 Issue:9 Volume:69 Page:917-927
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Feyerabend Susan,Stevanovic Stefan,Gouttefangeas Cécile,Wernet Dorothee,Hennenlotter Jörg,Bedke Jens,Dietz Klaus,Pascolo Steve,Kuczyk Markus,Rammensee Hans-Georg,Stenzl Arnulf

Publisher

Wiley

Subject

Urology,Oncology

Reference37 articles.

1. Estimates of the cancer incidence and mortality in Europe in2006;Ferlay;Ann Oncol,2007

2. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

3. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

4. Cancer control with radical prostatectomy alone in 1,000 consecutive patients;Hull;J Urol,2002

5. Failure after primary radiation or surgery for prostate cancer: differences in response to androgen ablation;Swanson;J Urol,2004

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens;Frontiers in Oncology;2024-08-26

2. FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion;Frontiers in Oncology;2024-03-28

3. Transplantable Murine Tumors in the Studies of Peptide Antitumor Vaccines;Oncology Reviews;2024-01-08

4. Peptide-based vaccine for cancer therapies;Frontiers in Immunology;2023-08-16

5. Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications;International Journal of Molecular Sciences;2023-07-23